Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oestrogen receptor values and histologic type and grade in breast carcinoma--a three year review.

Literature DB >> 2836337

Oestrogen receptor values and histologic type and grade in breast carcinoma--a three year review.

B M Loftus, C E Connolly.

Abstract

Entities: Disease

Mesh：

Substances：
Receptors, Estrogen

Year: 1988 PMID： 2836337 DOI： 10.1007/BF02953686

Source DB: PubMed Journal: Ir J Med Sci ISSN： 0021-1265 Impact factor: 1.568

× No keyword cloud information.

16 in total

1. Infiltrating lobular carcinoma of the breast.

Authors: R Ashikari; A G Huvos; J A Urban; G F Robbins
Journal: Cancer Date: 1973-01 Impact factor: 6.860

2. Tumor grade in the prognosis of breast cancer.

Authors: W J Eichner; H M Lemon; G Friedell
Journal: Nebr State Med J Date: 1970-07

3. Current concepts in cancer. Receptors in breast cancer.

Authors: M E Lippman; J C Allegra
Journal: N Engl J Med Date: 1978-10-26 Impact factor: 91.245

4. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.

Authors: M E Lippman; J C Allegra; E B Thompson; R Simon; A Barlock; L Green; K K Huff; H M Do; S C Aitken; R Warren
Journal: N Engl J Med Date: 1978-06-01 Impact factor: 91.245

5. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors: E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal: Cancer Date: 1975-07 Impact factor: 6.860

6. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

Authors: K S McCarty; L S Miller; E B Cox; J Konrath; K S McCarty
Journal: Arch Pathol Lab Med Date: 1985-08 Impact factor: 5.534

1. The expression and clinical significance of ERβ/ERα in ovarian cancer: can we predict the effectiveness of platinum plus taxane therapy?

Authors: Tatiana A Bogush; Anna A Basharina; Elena A Bogush; Alexander M Scherbakov; Mikhail M Davydov; Vyacheslav S Kosorukov
Journal: Ir J Med Sci Date: 2021-11-06 Impact factor: 2.089

1 in total

Oestrogen receptor values and histologic type and grade in breast carcinoma--a three year review.

1. Infiltrating lobular carcinoma of the breast.

2. Tumor grade in the prognosis of breast cancer.

3. Current concepts in cancer. Receptors in breast cancer.

4. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.

5. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

6. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

7. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.

8. Oestrogen receptor values and histological grade in human breast cancer.

9. Prognosis in carcinoma of the breast.

10. Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.

1. The expression and clinical significance of ERβ/ERα in ovarian cancer: can we predict the effectiveness of platinum plus taxane therapy?